Clinical

Dataset Information

0

A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer


ABSTRACT: This 2 arm study will compare the efficacy and safety of intermittent oral Xeloda plus Eloxatin (oxaliplatin) with that of fluorouracil/leucovorin in patients who have had surgery for colon cancer and no previous chemotherapy. Patients will be randomized to receive either 1) XELOX (Xeloda 1000mg/m2 po bid on days 1-15 + oxaliplatin) in 3 week cycles or 2)5-fluorouracil + leucovorin in 4 or 8 week cycles. The anticipated time on study treatment is until disease progression and the target sample size is 500+ individuals.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2009842 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2009841 | ecrin-mdr-crc
| 2009840 | ecrin-mdr-crc
| 2674808 | ecrin-mdr-crc
2020-01-28 | GSE138912 | GEO
2015-12-31 | GSE69657 | GEO
2015-12-31 | E-GEOD-69657 | biostudies-arrayexpress
| 2030953 | ecrin-mdr-crc
| 2013397 | ecrin-mdr-crc
2010-06-01 | GSE16718 | GEO
| 2090033 | ecrin-mdr-crc